Aarno Palotie is in charge of all genetic research for the project. DNA samples from subjects involved in EUROHEADPAIN research will be genotyped through his close contacts at Sanger and/or the Broad Institute (MIT-Boston). The FIMM group has been heavily involved in unravelling genetic factors for a variety complex neurological and neurodevelopmental traits, including migraine, schizophrenia, autism, and epilepsy and researchers at the Helsinki site have specifically built and are further developing expertise for combining next generation sequencing and genome wide genotype analysis, to identify variants predisposing to several complex traits.
Website UH-FIMM: Genomics of Neurological and Neuropsychiatric Disorders
- Leader of WP2
Aarno Palotie, MD, PhD, is Professor at WTSI and Director of the Human Genomics Program at the Finnish Institute of Molecular Medicine (FIMM). In addition, he is visiting professor at the Broad Institute of MIT and Harvard (Boston, USA).
Maija Wessman,PhD, is senior genetics researcher and group leader at the Folkhälsan Research Centre.
Priit Palta, PhD, is Postdoctoral fellow and heavily involved in the analysis of low frequency and rare variants that come from sequencing efforts.
Padhraig Gromley, PhD, is Postdoctoral fellow with a strong background in statistics, bioinformatics and machine learning. In addition, he is a key analyst in GWA and sequencing studies of complex traits.
Samuli Ripatti, PhD, is Professor in Biometry at Hjelt Institute and EMBL group leader at FIMM. Prof. Ripatti is a statistical geneticist with a special interest in genetics of cardiovascular traits, lipids, metabolomics and beyond.
Mikko Kallela, MD, PhD, is chief neurologist at Helsinki University Central Hospital with a long-standing expertise in phenotyping migraine patients. Dr. Kallela has collected a large cohort of samples (> 8500) of over 2000 migraine families.
Mari Kaunisto, PhD, is Postdoctoral Fellow with key expertise in linkage and association analyses.